CHARLES RIVER LABORATORIES (CRL) Stock News
NYSE:CRL - New York Stock Exchange, Inc. - US1598641074 - Common Stock - Currency: USD
CRL Latest News, Press Relases and Analysis
What's going on in today's session: S&P500 gap up and gap down stocks
Stay updated with the S&P500 gap up and gap down stocks on Friday. Get a glimpse of the market's movement during today's session.
What's going on in today's session: S&P500 movers
Get insights into the S&P500 index performance on Thursday. Explore the top gainers and losers within the S&P500 index in today's session.
Cathie Wood Agrees Circle IPO Is 'Crypto's ChatGPT Moment' — Warns Institutions That Ignoring The AI-Crypto Combo 'Just Isn't An Option'
ARK Invest CEO Cathie Wood agrees with Fundstrat Global Advisors Head of Research Tom Lee and has likened the Circle (NYSE:CRL) IPO to a pivotal moment in the crypto industry, suggesting that institutional investors can no longer ignore the co
Is Charles River Laboratories Stock Underperforming the S&P 500?
Despite Charles River Laboratories' weak performance relative to the broader S&P 500 Index over the past year, Wall Street analysts remain moderately optimistic about its prospects.
Charles River Announces Endosafe® Cartridge Recycling Program, Strengthening Sustainability Commitment
Why Is Charles River (CRL) Down 0.1% Since Last Earnings Report?
Charles River (CRL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Mentions: AVTR
Charles River Stock May Gain From Extended CHDI Research Deal on HD
CRL and CHDI Foundation extend their Huntington's disease partnership, boosting integration and global flexibility in drug discovery.
Charles River Laboratories to Present at William Blair and Jefferies Conferences
US court proceeds with Grifols defamation case against Gotham City, but narrows scope
MADRID (Reuters) -A New York court has found enough evidence to proceed with a defamation lawsuit filed by Grifols against short seller Gotham City Research, though it dismissed many of the Spanish pharmaceutical company's claims. The Federal District Court for the Southern District of New York rejected a request filed by Gotham City to dismiss the lawsuit, according to a ruling filed on Thursday. The court found that there was enough evidence to support Gotham's allegations that Grifols failed to disclose a $95 million loan to Scranton Enterprises, an entity tied to the drugmaker's founding family, were defamatory.
Charles River and CHDI Foundation Extend Multi-Decade Collaboration on Huntington’s Disease Research
Chefs’ Warehouse price target raised to $74 from $68 at BTIG
BTIG raised the firm’s price target on Chefs’ Warehouse (CHEF) to $74 from $68 and keeps a Buy rating on the shares after meeting with its management team. The firm expects Q1 sales strength to continue into Q2 and sees the company’s FY25 outlook as achievable, if not conservative, given the resilience seen in sales trends to-date, the analyst tells investors in a research note. Chefs’ Warehouse is harvesting post-COVID investments to drive several years of sales growth and margin expansion, wit
Baird Upgrades Wix.com (WIX) Stock, Cuts PT
On May 23, Baird analyst Vikram Kesavabhotla upped Wix.com Ltd. (NASDAQ:WIX)’s stock from “Neutral” to an “Outperform,” but reduced the price objective to $190 from the prior target of $215. The analyst noted a favourable outlook on the company, noting that Wix.com Ltd. (NASDAQ:WIX)’s product offerings have become significantly compelling, contributing to the decision to […]
Wells Fargo Upgrades Sonoco Products (SON) Stock, Lifts PT
On May 23, Wells Fargo analyst Gabe Hajde double upgraded Sonoco Products Company (NYSE:SON)’s stock to “Overweight” from “Underweight,” and raised the price objective to $55 from $45. As per the firm’s analyst, the efforts to simplify the company with an emphasis on fewer but larger businesses continue to reach the advanced stages. Furthermore, Wells […]
Craig-Hallum Upgrades PLAYSTUDIOS (MYPS), Raises Price Target
On May 23, Craig-Hallum upped PLAYSTUDIOS, Inc. (NASDAQ:MYPS)’s stock to “Buy” from “Hold,” increasing the price objective to $3 from $2. The firm mentioned that PLAYSTUDIOS, Inc. (NASDAQ:MYPS) continues to covertly test its sweepstakes casino “The Win Zone” with the help of selected players. As a result, Craig-Hallum managed to get a chance to try this out. […]